1. Home
  2. AKRO vs PSMT Comparison

AKRO vs PSMT Comparison

Compare AKRO & PSMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKRO
  • PSMT
  • Stock Information
  • Founded
  • AKRO 2017
  • PSMT 1994
  • Country
  • AKRO United States
  • PSMT United States
  • Employees
  • AKRO N/A
  • PSMT N/A
  • Industry
  • AKRO Biotechnology: Pharmaceutical Preparations
  • PSMT Department/Specialty Retail Stores
  • Sector
  • AKRO Health Care
  • PSMT Consumer Discretionary
  • Exchange
  • AKRO Nasdaq
  • PSMT Nasdaq
  • Market Cap
  • AKRO 3.7B
  • PSMT 3.6B
  • IPO Year
  • AKRO 2019
  • PSMT 1997
  • Fundamental
  • Price
  • AKRO $46.50
  • PSMT $121.27
  • Analyst Decision
  • AKRO Strong Buy
  • PSMT
  • Analyst Count
  • AKRO 8
  • PSMT 0
  • Target Price
  • AKRO $80.38
  • PSMT N/A
  • AVG Volume (30 Days)
  • AKRO 1.2M
  • PSMT 246.9K
  • Earning Date
  • AKRO 11-07-2025
  • PSMT 10-30-2025
  • Dividend Yield
  • AKRO N/A
  • PSMT 1.04%
  • EPS Growth
  • AKRO N/A
  • PSMT 15.87
  • EPS
  • AKRO N/A
  • PSMT 4.75
  • Revenue
  • AKRO N/A
  • PSMT $5,165,164,000.00
  • Revenue This Year
  • AKRO N/A
  • PSMT $9.55
  • Revenue Next Year
  • AKRO N/A
  • PSMT $8.86
  • P/E Ratio
  • AKRO N/A
  • PSMT $25.54
  • Revenue Growth
  • AKRO N/A
  • PSMT 7.47
  • 52 Week Low
  • AKRO $21.34
  • PSMT $81.25
  • 52 Week High
  • AKRO $58.40
  • PSMT $124.59
  • Technical
  • Relative Strength Index (RSI)
  • AKRO 47.87
  • PSMT 64.47
  • Support Level
  • AKRO $45.20
  • PSMT $119.31
  • Resistance Level
  • AKRO $47.40
  • PSMT $124.59
  • Average True Range (ATR)
  • AKRO 1.46
  • PSMT 2.54
  • MACD
  • AKRO 0.06
  • PSMT 0.16
  • Stochastic Oscillator
  • AKRO 34.90
  • PSMT 80.85

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.

About PSMT PriceSmart Inc.

Pricesmart Inc is principally engaged in operating U.S.-style membership shopping warehouse clubs that offer consumer goods at low prices. The company is headquartered in San Diego, California, United States, and operates stores in the Caribbean, Costa Rica, Panama, and other regions. The company's revenue consists of net warehouse club sales from merchandise sales, membership income from annual membership fees, export sales, and other income. Its operations consist of four reportable segments; Central America, the Caribbean, Colombia, and the United States. A majority of the company's revenue is derived from Central America.

Share on Social Networks: